Correlation Between Sangui Biotech and Eagle Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sangui Biotech and Eagle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangui Biotech and Eagle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sangui Biotech International and Eagle Pharmaceuticals, you can compare the effects of market volatilities on Sangui Biotech and Eagle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangui Biotech with a short position of Eagle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangui Biotech and Eagle Pharmaceuticals.

Diversification Opportunities for Sangui Biotech and Eagle Pharmaceuticals

0.0

Correlation Coefficient

Sangui Biotech  Eagle Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Sangui and Eagle is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sangui Biotech International and Eagle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eagle Pharmaceuticals and Sangui Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangui Biotech International are associated (or correlated) with Eagle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eagle Pharmaceuticals has no effect on the direction of Sangui Biotech i.e., Sangui Biotech and Eagle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sangui Biotech and Eagle Pharmaceuticals

If you would invest (100.00) in Eagle Pharmaceuticals on December 28, 2024 and sell it today you would earn a total of  100.00  from holding Eagle Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Sangui Biotech International  vs.  Eagle Pharmaceuticals

Sangui Biotech Inter

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Sangui Biotech is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Eagle Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Eagle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Eagle Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sangui Biotech and Eagle Pharmaceuticals

The main advantage of trading using opposite Sangui Biotech and Eagle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangui Biotech position performs unexpectedly, Eagle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eagle Pharmaceuticals will offset losses from the drop in Eagle Pharmaceuticals' long position.

The idea behind Sangui Biotech International and Eagle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.